 | • レポートコード：QYR2104Z1798 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、うつ病治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（SSRI、SNRI、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・うつ病治療薬の市場動向 ・企業の競争状況、市場シェア ・うつ病治療薬の種類別市場規模（SSRI、SNRI、その他） ・うつ病治療薬の用途別市場規模（病院、診療所、その他） ・うつ病治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・うつ病治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・うつ病治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・うつ病治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・うつ病治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Intellipharmaceutics、Pfizer、Eli Lilly、Astrazeneca、Lundbeck、Allergan、GSK、Otsuka Pharmaceutical、Takeda、NHU Group、Shionogi、APOTEX、Kanghong Pharma、HUAHAI） ・結論 |
Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.
The classification of Depression Drugs includes SSRIs, SNRIs and others, and the proportion of SSRIs in 2016 is about 47%, and the proportion of SNRIs in 2016 is about 34%.Depression Drugs is widely used in hospitals, clinics and other places. The most proportion of Depression Drugs is hospitals, and the proportion in 2016 is 679%. The trend of hospitals is increasing.
Market Analysis and Insights: Global Depression Drugs Market
The global Depression Drugs market size is projected to reach US$ 19490 million by 2026, from US$ 15920 million in 2019, at a CAGR of 2.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Depression Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Depression Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Depression Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Depression Drugs market.
Global Depression Drugs Scope and Market Size
Depression Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Depression Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
SSRIs
SNRIs
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Intellipharmaceutics
Pfizer
Eli Lilly
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
Astrazeneca
Lundbeck
APOTEX
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Depression Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 SSRIs
1.2.3 SNRIs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Depression Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Depression Drugs Market Perspective (2016-2027)
2.2 Depression Drugs Growth Trends by Regions
2.2.1 Depression Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Depression Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Depression Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Depression Drugs Industry Dynamic
2.3.1 Depression Drugs Market Trends
2.3.2 Depression Drugs Market Drivers
2.3.3 Depression Drugs Market Challenges
2.3.4 Depression Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Depression Drugs Players by Revenue
3.1.1 Global Top Depression Drugs Players by Revenue (2016-2021)
3.1.2 Global Depression Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Depression Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Depression Drugs Revenue
3.4 Global Depression Drugs Market Concentration Ratio
3.4.1 Global Depression Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Depression Drugs Revenue in 2020
3.5 Depression Drugs Key Players Head office and Area Served
3.6 Key Players Depression Drugs Product Solution and Service
3.7 Date of Enter into Depression Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Depression Drugs Breakdown Data by Type
4.1 Global Depression Drugs Historic Market Size by Type (2016-2021)
4.2 Global Depression Drugs Forecasted Market Size by Type (2022-2027)
5 Depression Drugs Breakdown Data by Application
5.1 Global Depression Drugs Historic Market Size by Application (2016-2021)
5.2 Global Depression Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Depression Drugs Market Size (2016-2027)
6.2 North America Depression Drugs Market Size by Type
6.2.1 North America Depression Drugs Market Size by Type (2016-2021)
6.2.2 North America Depression Drugs Market Size by Type (2022-2027)
6.2.3 North America Depression Drugs Market Size by Type (2016-2027)
6.3 North America Depression Drugs Market Size by Application
6.3.1 North America Depression Drugs Market Size by Application (2016-2021)
6.3.2 North America Depression Drugs Market Size by Application (2022-2027)
6.3.3 North America Depression Drugs Market Size by Application (2016-2027)
6.4 North America Depression Drugs Market Size by Country
6.4.1 North America Depression Drugs Market Size by Country (2016-2021)
6.4.2 North America Depression Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Depression Drugs Market Size (2016-2027)
7.2 Europe Depression Drugs Market Size by Type
7.2.1 Europe Depression Drugs Market Size by Type (2016-2021)
7.2.2 Europe Depression Drugs Market Size by Type (2022-2027)
7.2.3 Europe Depression Drugs Market Size by Type (2016-2027)
7.3 Europe Depression Drugs Market Size by Application
7.3.1 Europe Depression Drugs Market Size by Application (2016-2021)
7.3.2 Europe Depression Drugs Market Size by Application (2022-2027)
7.3.3 Europe Depression Drugs Market Size by Application (2016-2027)
7.4 Europe Depression Drugs Market Size by Country
7.4.1 Europe Depression Drugs Market Size by Country (2016-2021)
7.4.2 Europe Depression Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Depression Drugs Market Size (2016-2027)
8.2 Asia-Pacific Depression Drugs Market Size by Type
8.2.1 Asia-Pacific Depression Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Depression Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Depression Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Depression Drugs Market Size by Application
8.3.1 Asia-Pacific Depression Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Depression Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Depression Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Depression Drugs Market Size by Region
8.4.1 Asia-Pacific Depression Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Depression Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Depression Drugs Market Size (2016-2027)
9.2 Latin America Depression Drugs Market Size by Type
9.2.1 Latin America Depression Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Depression Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Depression Drugs Market Size by Type (2016-2027)
9.3 Latin America Depression Drugs Market Size by Application
9.3.1 Latin America Depression Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Depression Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Depression Drugs Market Size by Application (2016-2027)
9.4 Latin America Depression Drugs Market Size by Country
9.4.1 Latin America Depression Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Depression Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Depression Drugs Market Size (2016-2027)
10.2 Middle East & Africa Depression Drugs Market Size by Type
10.2.1 Middle East & Africa Depression Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Depression Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Depression Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Depression Drugs Market Size by Application
10.3.1 Middle East & Africa Depression Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Depression Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Depression Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Depression Drugs Market Size by Country
10.4.1 Middle East & Africa Depression Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Depression Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Intellipharmaceutics
11.1.1 Intellipharmaceutics Company Details
11.1.2 Intellipharmaceutics Business Overview
11.1.3 Intellipharmaceutics Depression Drugs Introduction
11.1.4 Intellipharmaceutics Revenue in Depression Drugs Business (2016-2021)
11.1.5 Intellipharmaceutics Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Depression Drugs Introduction
11.2.4 Pfizer Revenue in Depression Drugs Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Depression Drugs Introduction
11.3.4 Eli Lilly Revenue in Depression Drugs Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Astrazeneca
11.4.1 Astrazeneca Company Details
11.4.2 Astrazeneca Business Overview
11.4.3 Astrazeneca Depression Drugs Introduction
11.4.4 Astrazeneca Revenue in Depression Drugs Business (2016-2021)
11.4.5 Astrazeneca Recent Development
11.5 Lundbeck
11.5.1 Lundbeck Company Details
11.5.2 Lundbeck Business Overview
11.5.3 Lundbeck Depression Drugs Introduction
11.5.4 Lundbeck Revenue in Depression Drugs Business (2016-2021)
11.5.5 Lundbeck Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Depression Drugs Introduction
11.6.4 Allergan Revenue in Depression Drugs Business (2016-2021)
11.6.5 Allergan Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Depression Drugs Introduction
11.7.4 GSK Revenue in Depression Drugs Business (2016-2021)
11.7.5 GSK Recent Development
11.8 Otsuka Pharmaceutical
11.8.1 Otsuka Pharmaceutical Company Details
11.8.2 Otsuka Pharmaceutical Business Overview
11.8.3 Otsuka Pharmaceutical Depression Drugs Introduction
11.8.4 Otsuka Pharmaceutical Revenue in Depression Drugs Business (2016-2021)
11.8.5 Otsuka Pharmaceutical Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Depression Drugs Introduction
11.9.4 Takeda Revenue in Depression Drugs Business (2016-2021)
11.9.5 Takeda Recent Development
11.10 NHU Group
11.10.1 NHU Group Company Details
11.10.2 NHU Group Business Overview
11.10.3 NHU Group Depression Drugs Introduction
11.10.4 NHU Group Revenue in Depression Drugs Business (2016-2021)
11.10.5 NHU Group Recent Development
11.11 Shionogi
11.11.1 Shionogi Company Details
11.11.2 Shionogi Business Overview
11.11.3 Shionogi Depression Drugs Introduction
11.11.4 Shionogi Revenue in Depression Drugs Business (2016-2021)
11.11.5 Shionogi Recent Development
11.12 APOTEX
11.12.1 APOTEX Company Details
11.12.2 APOTEX Business Overview
11.12.3 APOTEX Depression Drugs Introduction
11.12.4 APOTEX Revenue in Depression Drugs Business (2016-2021)
11.12.5 APOTEX Recent Development
11.13 Kanghong Pharma
11.13.1 Kanghong Pharma Company Details
11.13.2 Kanghong Pharma Business Overview
11.13.3 Kanghong Pharma Depression Drugs Introduction
11.13.4 Kanghong Pharma Revenue in Depression Drugs Business (2016-2021)
11.13.5 Kanghong Pharma Recent Development
11.14 HUAHAI
11.14.1 HUAHAI Company Details
11.14.2 HUAHAI Business Overview
11.14.3 HUAHAI Depression Drugs Introduction
11.14.4 HUAHAI Revenue in Depression Drugs Business (2016-2021)
11.14.5 HUAHAI Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Depression Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of SSRIs
Table 3. Key Players of SNRIs
Table 4. Key Players of Others
Table 5. Global Depression Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Depression Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Depression Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Depression Drugs Market Share by Regions (2016-2021)
Table 9. Global Depression Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Depression Drugs Market Share by Regions (2022-2027)
Table 11. Depression Drugs Market Trends
Table 12. Depression Drugs Market Drivers
Table 13. Depression Drugs Market Challenges
Table 14. Depression Drugs Market Restraints
Table 15. Global Depression Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Depression Drugs Market Share by Players (2016-2021)
Table 17. Global Top Depression Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depression Drugs as of 2020)
Table 18. Ranking of Global Top Depression Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Depression Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Depression Drugs Product Solution and Service
Table 22. Date of Enter into Depression Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Depression Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Depression Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Depression Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Depression Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Depression Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Depression Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Depression Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Depression Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Depression Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Depression Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Depression Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Depression Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Depression Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Depression Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Depression Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Depression Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Depression Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Depression Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Depression Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Depression Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Depression Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Depression Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Depression Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Depression Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Depression Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Depression Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Depression Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Depression Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Depression Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Depression Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Depression Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Depression Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Depression Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Depression Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Depression Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Depression Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Depression Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Depression Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Intellipharmaceutics Company Details
Table 63. Intellipharmaceutics Business Overview
Table 64. Intellipharmaceutics Depression Drugs Product
Table 65. Intellipharmaceutics Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 66. Intellipharmaceutics Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Depression Drugs Product
Table 70. Pfizer Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Depression Drugs Product
Table 75. Eli Lilly Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. Astrazeneca Company Details
Table 78. Astrazeneca Business Overview
Table 79. Astrazeneca Depression Drugs Product
Table 80. Astrazeneca Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 81. Astrazeneca Recent Development
Table 82. Lundbeck Company Details
Table 83. Lundbeck Business Overview
Table 84. Lundbeck Depression Drugs Product
Table 85. Lundbeck Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 86. Lundbeck Recent Development
Table 87. Allergan Company Details
Table 88. Allergan Business Overview
Table 89. Allergan Depression Drugs Product
Table 90. Allergan Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 91. Allergan Recent Development
Table 92. GSK Company Details
Table 93. GSK Business Overview
Table 94. GSK Depression Drugs Product
Table 95. GSK Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 96. GSK Recent Development
Table 97. Otsuka Pharmaceutical Company Details
Table 98. Otsuka Pharmaceutical Business Overview
Table 99. Otsuka Pharmaceutical Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 100. Otsuka Pharmaceutical Recent Development
Table 101. Takeda Company Details
Table 102. Takeda Business Overview
Table 103. Takeda Depression Drugs Product
Table 104. Takeda Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 105. Takeda Recent Development
Table 106. NHU Group Company Details
Table 107. NHU Group Business Overview
Table 108. NHU Group Depression Drugs Product
Table 109. NHU Group Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 110. NHU Group Recent Development
Table 111. Shionogi Company Details
Table 112. Shionogi Business Overview
Table 113. Shionogi Depression Drugs Product
Table 114. Shionogi Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 115. Shionogi Recent Development
Table 116. APOTEX Company Details
Table 117. APOTEX Business Overview
Table 118. APOTEX Depression Drugs Product
Table 119. APOTEX Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 120. APOTEX Recent Development
Table 121. Kanghong Pharma Company Details
Table 122. Kanghong Pharma Business Overview
Table 123. Kanghong Pharma Depression Drugs Product
Table 124. Kanghong Pharma Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 125. Kanghong Pharma Recent Development
Table 126. HUAHAI Company Details
Table 127. HUAHAI Business Overview
Table 128. HUAHAI Depression Drugs Product
Table 129. HUAHAI Revenue in Depression Drugs Business (2016-2021) & (US$ Million)
Table 130. HUAHAI Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Depression Drugs Market Share by Type: 2020 VS 2027
Figure 2. SSRIs Features
Figure 3. SNRIs Features
Figure 4. Others Features
Figure 5. Global Depression Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Depression Drugs Report Years Considered
Figure 10. Global Depression Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Depression Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Depression Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Depression Drugs Market Share by Regions (2022-2027)
Figure 14. Global Depression Drugs Market Share by Players in 2020
Figure 15. Global Top Depression Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depression Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Depression Drugs Revenue in 2020
Figure 17. Global Depression Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Depression Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Depression Drugs Market Share by Type (2016-2027)
Figure 21. North America Depression Drugs Market Share by Application (2016-2027)
Figure 22. North America Depression Drugs Market Share by Country (2016-2027)
Figure 23. United States Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Depression Drugs Market Share by Type (2016-2027)
Figure 27. Europe Depression Drugs Market Share by Application (2016-2027)
Figure 28. Europe Depression Drugs Market Share by Country (2016-2027)
Figure 29. Germany Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Depression Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Depression Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Depression Drugs Market Share by Region (2016-2027)
Figure 39. China Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Depression Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Depression Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Depression Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Depression Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Depression Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Depression Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Depression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Intellipharmaceutics Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 60. Eli Lilly Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 61. Astrazeneca Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 62. Lundbeck Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 63. Allergan Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 64. GSK Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 65. Otsuka Pharmaceutical Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 66. Takeda Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 67. NHU Group Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 68. Shionogi Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 69. APOTEX Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 70. Kanghong Pharma Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 71. HUAHAI Revenue Growth Rate in Depression Drugs Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の産後うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Postpartum Depression Treatment Market The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…- 世界の産後うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Postpartum Depression Treatment Market The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
- 世界の産後うつ病治療薬市場規模・現状・予測（2021年-2027年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
- 世界のうつ病治療用療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Depression Treatment Therapy Market The global Depression Treatment Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…
- 世界のうつ病治療薬市場 2021：企業別、地域別、種類・用途別 The Depression Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…